Is increased systemic immune-inflammation index associated with all-cause mortality in patients with ASCVD?
The systemic immune-inflammation index may serve as a prognostic marker for survival in patients with arteriosclerotic cardiovascular disease.
An association was detected between the baseline ln-SII and all-cause mortality in a United States ASCVD population. Increased SII is associated with poor survival in individuals with ASCVD.
He et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: